Article
Nitric oxide synthase II suppresses the growth and metastasis of human cancer regardless of its up-regulation of protumor factors.
Proceedings of the National Academy of Sciences of the United States of America - 14 Jun 2005
Le Xiangdong, Wei Daoyan, Huang Suyun, Lancaster Jack R, Xie Keping
Abstract excerpt
Inducible nitric oxide (NO) synthase (NOS) II has been implicated in macrophage-mediated antitumor activity. However, use of the NOS II gene in cancer therapy is problematic because of the double-edged nature of NO action. Herein we show that adenoviral vectors mediated effective NOS II gene transfer into various human tumors. Production of NO significantly up-regulated multiple angiogenic molecules. However, the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
